0001144204-17-004094.txt : 20170126
0001144204-17-004094.hdr.sgml : 20170126
20170126175644
ACCESSION NUMBER: 0001144204-17-004094
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170125
FILED AS OF DATE: 20170126
DATE AS OF CHANGE: 20170126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC
CENTRAL INDEX KEY: 0001037649
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 943123681
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 135 BEAVER ST
CITY: WATHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 1-781-398-0700
MAIL ADDRESS:
STREET 1: 135 BEAVER ST
CITY: WATHAM
STATE: MA
ZIP: 02452
FORMER COMPANY:
FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC
DATE OF NAME CHANGE: 19971003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Toutain Stephan
CENTRAL INDEX KEY: 0001681658
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32715
FILM NUMBER: 17551160
MAIL ADDRESS:
STREET 1: 135 BEAVER STREET
STREET 2: C/O INTERLEUKIN GENETICS, INC.
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
v457637_form4.xml
FORM 4
X0306
4
2017-01-25
0
0001037649
INTERLEUKIN GENETICS INC
ILIU
0001681658
Toutain Stephan
C/O INTERLEUKIN GENETICS, INC.
135 BEAVER STREET
WALTHAM
MA
02452
0
1
0
0
Chief Commercial Officer
Stock Option (Right to Buy)
0.1237
2017-01-25
4
A
0
365093
0
A
2027-01-25
Common Stock
365093
365093
D
The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on January 25, 2017, which was the grant date of the option.
The option vests as to 25% of the shares on January 25, 2018, and 1/36th of the shares on the first day of each month beginning on February 1, 2018.
/s/ Brian P. Keane, Attorney-in-Fact
2017-01-26